| AMARIN CORP.ADR NEW 2025 |
| USA |
| Gesundheit |
| US0231114044 / A41557 |
| EH3 (Frankfurt) / AMRN (NASDAQ) |
| FRA:EH3, ETR:EH3, EH3:GR, NASDAQ:AMRN |
| - |
| https://www.amarincorp.co.. |
|
Amarin Corporation plc is a biopharmaceutical company specializing in the development and commercialization of therapeutics aimed at improving cardiovascular health and reducing cardiovascular risk. I..
>Volltext.. |
| 276.11 Mio. EUR |
| 38.15 Mio. EUR |
| 192.73 Mio. EUR |
| -51.49 Mio. EUR |
| -72.98 Mio. EUR |
| -3.54 EUR |
| 5.72 Mio. EUR |
| 104.56 Mio. EUR |
| -18.54 Mio. EUR |
| 1.57 |
| -6.29% |
| -116.73% |
| - |
| - |
| - |
| - |
| AMARIN |
| 25.02.26 |
|